Concepedia
4
Publications
1.4K
Citations
H-Index
2013
Active since
Affiliations
The Ohio State University(Current)
Pharmacyclics (United States)
Cornell University
Kelly A. Smucker is an author at The Ohio State University.
Publications per year
2013–2015
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
Jason A. Dubovsky, Kyle A. Beckwith, Gayathri Natarajan et al. · Blood · 2013 · 783 citations · Full text
Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy
Jennifer A. Woyach, Kelly A. Smucker, Lisa L. Smith et al. · Blood · 2014 · 273 citations · Full text
Bruton’s tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)
Jennifer A. Woyach, Engin Bojnik, Amy S. Ruppert et al. · Blood · 2013 · 213 citations · Full text
Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study
Samantha Jaglowski, Jeffrey A. Jones, Veena Nagar et al. · Blood · 2015 · 131 citations · Full text
Rows per page
1–4 of 4